CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 270 enrolled
Drug / intervention
Relational agent/AliveCor Kardia - Intervention +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04076020
NCT04076020N/ACompleted

Mobile Health Intervention for Rural Atrial Fibrillation

University of Pittsburgh·interventional·Posted Sep 3, 2019·Updated May 30, 2024

In Brief

A clinical study evaluating Relational agent/AliveCor Kardia - Intervention and Usual Care for Atrial Fibrillation and 4 related conditions. Completed, enrolled 270 participants across 1 site.

Detailed Summary

Atrial fibrillation (AF) is a highly prevalent, morbid condition. Anticoagulation to prevent thromboembolic strokes is a foremost priority in AF but adherence is challenging for patients and lapses in anticoagulation are common. Chronic disease self-management (CDSM) is a recognized program to enhance self-efficacy and improve adherence, quality of life, and patient-centered health outcomes. Rural patients with AF experience increased vulnerability to adverse outcomes due to geographic and social isolation, poor health care access, and limited health literacy. This study uses an innovative, scalable CDSM intervention to improve anticoagulation adherence in rural patients with AF.

Study Details

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 3, 2019
Enrollment StartJan 8, 2020
Primary CompletionMay 27, 2023
Study CompletionAug 2, 2023
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 6.8 years ago

Interventions

Relational agent/AliveCor Kardia - Interventionbehavioral

Use of the relational agent and Kardia daily for 120 days.

Usual Carebehavioral

Use of the WebMD app daily for 120 days.